Maira Dastgir N on Microvascular Dysfunction in Geriatrics
Maira Dastgir N, Global Chief of Transitional Care for Global Population Healthcare Management Forum, shared on LinkedIn:
”In geriatric care, we often focus on macro events like heart attacks or strokes.
However, the root of many geriatric syndromes like dementia, depression, and frailty often lies at the microvascular level.
I reviewed an interesting article recently that caught my attention, The Maastricht Study findings on alcohol and Microvascular Dysfunction (MVD).
The researchers found a J-shaped association which meant light-to-moderate consumption was linked to lower MVD compared to abstinence, while high consumption worsened it.
As primary care doctors, we are dedicated to prevention and often view alcohol through a binary lens of “healthy” vs. “unhealthy.”
But for our aging population, the microvasculature is the frontline of defense against cognitive decline and physical frailty. This study suggests that:
1) Dietary interventions are not one-size-fits-all. The way a patient’s body handles alcohol and its impact on small vessels depends heavily on their metabolic profile.
2) The “Micro” is the Key to the “Macro”. By the time a patient presents with geriatric syndromes like depression or dementia, microvascular damage may already be advanced. We must broaden our horizons to include early microvascular screening as a preventive standard.
3) While we cannot and should not recommend increasing alcohol intake as a broad policy, we must understand these biological nuances to provide truly personalized geriatric care.
Shifting our focus from large-vessel events to early microvascular screening and dietary nuances can help diagnose minor dysfunction before it becomes a major clinical disease.
I have linked the article here.”
Article: Alcohol consumption and microvascular dysfunction: a J-shaped association: The Maastricht Study
Authors: Frank C. T. van der Heide, Simone J. P. M. Eussen, Alfons J. H. M. Houben, Ronald M. A. Henry, Abraham A. Kroon, Carla J. H. van der Kallen, Pieter C. Dagnelie, Martien C. J. M. van Dongen, Tos T. J. M. Berendschot, Jan S. A. G. Schouten, Carroll A. B. Webers, Marleen M. J. van Greevenbroek, Anke Wesselius, Casper G. Schalkwijk, Annemarie Koster, Jacobus F. A. Jansen, Walter H. Backes, Joline W. J. Beulens, Coen D. A. Stehouwer
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 19, 2026, 15:59Nour Al-Mozain: Why Stem Cell Collection Parameters Need Adjustment in SCD for Gene Therapy?
-
Apr 19, 2026, 15:42S. Kate Hartman: A Clinical Framework for Anemia, Bleeding, and Transfusion Decision-Making
-
Apr 19, 2026, 15:20CHAMPION-AF Demonstrated Better Freedom From Clinically Relevant Bleeding Events – Boston Scientific Cardiology
-
Apr 19, 2026, 14:37Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
-
Apr 19, 2026, 14:36Francisco Ujueta: Pulmonary Embolism Care Doesn’t End at the Acute Phase
-
Apr 19, 2026, 14:35Flora Peyvandi: Marking the Beginning of a Future with Less Suffering on World Haemophilia Day
-
Apr 19, 2026, 14:34Chokri Ben Lamine: 50 High-Yield Pearls on Hemoglobin Cutoffs for Anaemia from WHO 2024 Guideline
-
Apr 19, 2026, 14:31Kate Iyore: Simple Explanation of Deep Vein Thrombosis and Pulmonary Embolism
-
Apr 19, 2026, 14:08Emily Smith: From Personal Experience to Global Advocacy on World Haemophilia Day